PharmaShots | Incisive News in 3 Shots

Subscribe Now

Acer Therapeutics

Acer Therapeutics Regained the Development and Commercialization Rights for Olpruva from Relief Therapeutics for Areas Excluding Geographical Europe

Acer Therapeutics Regained the Development and Commercialization Rights for Olpruva from Relief Therapeutics for Areas Excluding G...

August 31, 2023

Acer Therapeutics and Relief Therapeutics Receive the US FDA’s Approval of Olpruva for Urea Cycle Disorders

Acer Therapeutics and Relief Therapeutics Receive the US FDA’s Approval of Olpruva for Urea Cycle Disorders

December 27, 2022

Acer Therapeutics and Relief Receive the US FDA’s CRL for ACER-001’s NDA to Treat Urea Cycle Disorders

Acer Therapeutics and Relief Receive the US FDA’s CRL for ACER-001’s NDA to Treat Urea Cycle Disorders

June 22, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us